Providing Today's Patients with Medicines of the Future.
Staff
2017-2019 Net Profit CAGR
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions
On June 20, 2025, Simcere Pharmaceutical (2096.HK) announced that QUVIVIQ® (generic name: Daridorexant Hydrochloride Tablets), an anti-insomni...
Shanghai, China, June 18, 2025 — Simcere Zaiming, an innovative oncology-focused subsidiary of Simcere Pharmaceutical Group (2096.HK) today announc...
- NextCure gains global rights to SIM0505 excluding greater China, where Simcere Zaiming will retain rights- ...
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago from May 30 to June 03 2025 is one of the most important globa...